Abstract |
252Cf was used to treat tumors of the cervix in an ongoing clinical trial. Tandem and ovoids were used as well as a combination of single and multiple applications. Dosimetric analysis of these treated cases revealed the patterns of neutron dose rate and neutron/gamma ray dose ratios which were achievable using a variety of loading arrangements. Although pelvic tumor reference points and tissue dose was in general similar whether a tandem or tandem plus ovoids were used, vaginal dose was increased over two-fold or more by the use of vaginal applicators and sources. This indicates that a variety of individualized arrangements for different clinical presentations can be used for brachytherapy of gynecological pelvic neoplasm.
|
Authors | Y Maruyama, D L Tai, J L Beach |
Journal | Radiation medicine
(Radiat Med)
1983 Jul-Sep
Vol. 1
Issue 3
Pg. 230-6
ISSN: 0288-2043 [Print] Japan |
PMID | 6390538
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Brachytherapy
(methods)
- Californium
(administration & dosage, therapeutic use)
- Clinical Trials as Topic
- Female
- Gamma Rays
- Humans
- Neoplasm Staging
- Neutrons
- Radiotherapy Dosage
- Uterine Cervical Neoplasms
(pathology, radiotherapy)
- Vagina
|